Oxos Medical has received clearance from the U.S. Food and Drug Administration (FDA) for its MC2 ultraportable x-ray system.
MC2 is cordless and lightweight and offers dynamic digital radiography and fluoroscopy in addition to static imaging capabilities, according to Oxos. It features a patented positioning system designed to assist in alignment for image capture. MC2’s small scatter area and low radiation output can reduce the space and infrastructure needs required by larger systems, the company said.
MC2 is the latest release from Oxos, which launched its first device, the Micro C portable x-ray system, in 2021.